Yuehui Zhao

The University of Texas MD Anderson Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index493citations92works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(74), Prostate Cancer Treatment and Research(71), Genetic factors in colorectal cancer(46), Genetics, Aging, and Longevity in Model Organisms(13), Evolution and Genetic Dynamics(7)

Publications92 total

Phf6 truncating mutation drives leukemogenesis via disrupted epigenetic regulation in mice
Leukemia·2026
Figure S1 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S6 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S8 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S18 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S17 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S7 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S4 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S2 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S24 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S1 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S5 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S14 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S4 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S16 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S9 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S3 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S3 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S7 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S11 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
page 1 of 5Next →

Frequent Co-authors

Ana M. Aparicio(29), Emi Sei(28), Shanshan Bai(28), Amado J. Zurita(28), Nicholas E. Navin(28), Christopher J. Logothetis(27), Naveen Ramesh(26), Patricia Troncoso(26), Paul G. Corn(26), Ping Xu(25), Min Hu(25), Patrick T. McGrath(14), Lijiang Long(10), Erik C. Andersen(7), Wen Xu(7), Shannon C. Brady(5), Richard F. Campbell(3), Edward Large(3), Joshua S. Greene(3), Hang Lu(3)